Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2021.01.04.21249227: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources For the included studies, we searched PubMed and MedRxiv for design papers, study protocols or published results of those studies. PubMedsuggested: (PubMed, RRID:SCR_004846)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage …SciScore for 10.1101/2021.01.04.21249227: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources For the included studies, we searched PubMed and MedRxiv for design papers, study protocols or published results of those studies. PubMedsuggested: (PubMed, RRID:SCR_004846)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: We found the following clinical trial numbers in your paper:
Identifier Status Title NCT04508023 Recruiting A Study of Rivaroxaban to Reduce the Risk of Major Venous an… NCT04504032 Active, not recruiting A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVI… NCT04445623 Not yet recruiting Prasugrel in Severe COVID-19 Pneumonia NCT04360824 Recruiting Covid-19 Associated Coagulopathy NCT04389840 Recruiting Dociparstat for the Treatment of Severe COVID-19 in Adults a… NCT04420299 Recruiting Clinical Trial on the Efficacy and Safety of Bemiparin in Pa… NCT04397510 Enrolling by invitation Nebulized Heparin for the Treatment of COVID-19 Induced Lung… NCT04505592 Recruiting Tenecteplase in Patients With COVID-19 NCT04418128 Not yet recruiting Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumo… NCT04623021 Completed A Study Evaluating the Efficacy and Safety of CKD-314 (Nafab… NCT04650087 Recruiting COVID-19 Thrombosis Prevention Trials: Post-hospital Thrombo… NCT04662684 Recruiting Medically Ill Hospitalized Patients for COVID-19 THrombosis … NCT04508439 Recruiting Effect of the Use of Anticoagulant Therapy During Hospitaliz… Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
